AKSY Stock Overview

Provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. More details

AKSY fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap ($32)

My Notes

Capture your thoughts, links and company narrative

Aksys Ltd. Competitors

Motus GI Holdings

OTCPK:MOTS

US$1.4k

ThermoGenesis Holdings

OTCPK:THMO

US$4.8k

BIMI Holdings

OTCPK:BIMI

US$1.4k

UpHealth

OTCPK:UPHL

US$3.8k

Price History & Performance

Summary of share price highs, lows and changes for Aksys
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.75%
5 Year Change	0%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	AKSY	US Medical Equipment	US Market
7D	0%	-0.3%	-0.3%
1Y	n/a	12.4%	20.4%

Return vs Industry: Insufficient data to determine how AKSY performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how AKSY performed against the US Market.

Price Volatility

Is AKSY's price volatile compared to industry and market?
AKSY volatility
AKSY Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: AKSY has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine AKSY's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1991	n/a	n/a	n/a

Aksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient’s blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters.

Aksys Ltd. Fundamentals Summary

How do Aksys's earnings and revenue compare to its market cap?
AKSY fundamental statistics
Market cap	US$32.00
Earnings (TTM)	-US$54.81m
Revenue (TTM)	US$2.60m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is AKSY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AKSY income statement (TTM)
Revenue	US$2.60m
Cost of Revenue	US$7.21m
Gross Profit	-US$4.61m
Other Expenses	US$50.20m
Earnings	-US$54.81m

Last Reported Earnings

Sep 30, 2006

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did AKSY perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/06/10 15:33
End of Day Share Price	2024/03/13 00:00
Earnings	2006/09/30
Annual Earnings	2005/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aksys Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.